RNA 7-Methylguanosine (m7G) modification is biologically important to tumorigenesis and progression.
Knowledge regarding the effect of m7G modification on the clinical features of hepatocellular carcinoma and its prognosis, tumor immune microenvironment, and sensitivity to immunotherapy remains limited.
